27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published on Monday, Wedbush analyst Gregory R. Wade downgraded XenoPort (NASDAQ: XNPT) from Outperform to Neutral and lowered the price target for the company from $16 to $6.
In the report, Wedbush stated that, "We are downgrading XNPT shares to NEUTRAL from OUTPERFORM after the failure of Arbaclofen Placarbil (AP) in a Phase III trial for multiple sclerosis (MS) spasticity. XNPT announced that they will discontinue further development of Arbaclofen Placarbil. We are removing our valuation for AP from our price target, which we are reducing to $6 per share from $16 per share."
XenoPort closed at $6.75 on Friday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!